Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials

被引:125
作者
DiazGranados, Carlos A. [1 ]
Denis, Martine [2 ]
Plotkin, Stanley [3 ,4 ]
机构
[1] Sanofi Pasteur, Swiftwater, PA 18370 USA
[2] Sanofi Pasteur, F-69280 Marcy Letoile, France
[3] Univ Penn, Doylestown, PA 18902 USA
[4] Vaxconsult, Doylestown, PA 18902 USA
关键词
Influenza vaccines; Prevention and control; Treatment outcome; Meta-analysis; CULTURE-CONFIRMED INFLUENZA; YOUNG-CHILDREN; VIRUS-VACCINE; INTRANASAL INFLUENZA; INACTIVATED VACCINES; CLINICAL-TRIALS; HEALTHY-ADULTS; DOUBLE-BLIND; LIVE; TRIVALENT;
D O I
10.1016/j.vaccine.2012.10.084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Context: The true level of influenza vaccine efficacy is controversial and many factors may influence its estimation. Objectives: To estimate the efficacy of vaccination of children and non-elderly adults for the prevention of influenza and to explore the impact of type of vaccine, age, degree of strain matching, influenza type and case ascertainment methods on vaccine efficacy estimates. Data sources: Medline and EmBase databases until October 2011. References of relevant articles were also reviewed. Study selection: Controlled trials evaluating seasonal influenza vaccines and presenting incidence of laboratory-confirmed influenza illness were eligible. Studies exploring efficacy after experimental challenge, presenting duplicate data, employing group randomization, or focusing on special populations were excluded. Data extraction: The vaccine effect on influenza prevention was evaluated by calculating Mantel-Haenszel risk ratios (RR) and using random-effects models. Vaccine efficacies were calculated for each comparison as (1 - RR) x 100. Results: Thirty studies were included in one or more of a total of 101 analyses, comprising 88.468 study participants. There was evidence of heterogeneity in 49% of the analyses. Summary vaccine efficacy was 65% against any strain, 78% against matched strains and 55% against not-matched strains. Both live-attenuated and inactivated vaccines showed similar levels of protection against not-matched strains (60% and 55%, respectively). Live-attenuated vaccines performed better than inactivated vaccines in children (80% versus 48%), whereas inactivated vaccines performed better than live-attenuated vaccines in adults (59% versus 39%). There was a large difference (20%) in efficacy against influenza A (69%) and influenza B (49%) types for not-matched strains. Summary estimates of vaccine efficacy were highest when ascertainment was based on culture confirmation. Conclusion: Influenza vaccines are efficacious, but efficacy estimates depend on many variables including type of vaccine and age of vaccinees, degree of matching of the circulating strains to the vaccine, influenza type, and methods of case ascertainment. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 65 条
[1]   PLACEBO-CONTROLLED DOUBLE-BLIND CLINICAL STUDIES ON EFFICACY OF DIFFERENT INFLUENZA VACCINES ASSESSED BY EXPERIMENTAL AND NATURAL INFECTION [J].
ANDRE, FE ;
UYTTERSCHAUT, P ;
NICULESCU, ITI ;
VIRLAN, G ;
ZILISTEANU, E ;
SMERDEL, S ;
VODOPIJA, I .
POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (608) :352-359
[2]   Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates [J].
Ansaldi, Filippo ;
Zancolli, Marta ;
Durando, Paolo ;
Montomoli, Emanuele ;
Sticchi, Laura ;
Del Giudice, Giuseppe ;
Icardi, Giancarlo .
VACCINE, 2010, 28 (25) :4123-4129
[3]   Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections [J].
Ashkenazi, Shai ;
Vertruyen, Andre ;
Aristegui, Javier ;
Esposito, Susanna ;
McKeith, David Douglas ;
Klemola, Timo ;
Biolek, Jiri ;
Kuehr, Joachim ;
Bujnowski, Tadeusz ;
Desgrandchamps, Daniel ;
Cheng, Sheau-Mei ;
Skinner, Jonathan ;
Gruber, William C. ;
Forrest, Bruce D. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :870-879
[4]   Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled, trial [J].
Barrett, P. Noel ;
Berezuk, Gregory ;
Fritsch, Sandor ;
Aichinger, Gerald ;
Hart, Mary Kate ;
El-Amin, Wael ;
Kistner, Otfried ;
Ehrlich, Hartmut J. .
LANCET, 2011, 377 (9767) :751-759
[5]   Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Cho, I ;
Reisinger, K ;
Block, SL ;
Wittes, J ;
Iacuzio, D ;
Piedra, P ;
Treanor, J ;
King, J ;
Kotloff, K ;
Bernstein, DI ;
Hayden, FG ;
Zangwill, K ;
Yan, LH ;
Wolff, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :168-175
[6]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[7]   The need for quadrivalent vaccine against seasonal influenza [J].
Belshe, Robert B. .
VACCINE, 2010, 28 :D45-D53
[8]   Efficacy of Inactivated Split-Virus Influenza Vaccine against Culture-Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo-Controlled Trial [J].
Beran, Jiri ;
Vesikari, Timo ;
Wertzova, Veronika ;
Karvonen, Aino ;
Honegr, Karel ;
Lindblad, Niklas ;
Van Belle, Pascale ;
Peeters, Mathieu ;
Innis, Bruce L. ;
Devaster, Jeanne-Marie .
JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (12) :1861-1869
[9]   Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example [J].
Beran, Jiri ;
Wertzova, Veronika ;
Honegr, Karel ;
Kaliskova, Eva ;
Havlickova, Martina ;
Havlik, Jiri ;
Jirincova, Helena ;
Van Belle, Pascale ;
Jain, Varsha ;
Innis, Bruce ;
Devaster, Jeanne-Marie .
BMC INFECTIOUS DISEASES, 2009, 9
[10]   EVALUATION OF A NEURAMINIDASE-SPECIFIC INFLUENZA-A VIRUS-VACCINE IN CHILDREN - ANTIBODY-RESPONSES AND EFFECTS ON 2 SUCCESSIVE OUTBREAKS OF NATURAL INFECTION [J].
BEUTNER, KR ;
CHOW, T ;
RUBI, E ;
STRUSSENBERG, J ;
CLEMENT, J ;
OGRA, PL .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (06) :844-850